Skip to content
Trial Eligibility
Menu

Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg

NCT07705893

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The objective of this study is to evaluate whether twice-daily use of Tyrvaya improves contact lens comfort in contact lens wearers.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Dry Eye

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 99 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Ocular Aesthetics, LLC dba Ocular Clinical Trials
Last updated on ClinicalTrials.gov
July 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • Ocular Clinical Trials · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.